U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H27NO3
Molecular Weight 341.444
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of UR-144 N-PENTANOIC ACID

SMILES

CC1(C)C(C(=O)C2=CN(CCCCC(O)=O)C3=CC=CC=C23)C1(C)C

InChI

InChIKey=UUTHIAPDCFFQKQ-UHFFFAOYSA-N
InChI=1S/C21H27NO3/c1-20(2)19(21(20,3)4)18(25)15-13-22(12-8-7-11-17(23)24)16-10-6-5-9-14(15)16/h5-6,9-10,13,19H,7-8,11-12H2,1-4H3,(H,23,24)

HIDE SMILES / InChI

Molecular Formula C21H27NO3
Molecular Weight 341.444
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://encrypted.google.com/patents/EP2781527B1 | https://www.ncbi.nlm.nih.gov/pubmed/28771321

UR-144 N-pentanoic acid is a potent synthetic cannabinoid designed by Abbott Laboratories as a CB2 selective agonist for pain management. UR-144 N-pentanoic acid is a metabolite of another CB2-selective cannabinoid UR-144. Pre-clinical studies of nociceptive and neuropathic pain have shown that CB2-selective ligands are analgesics without causing the adverse side effects linked with CB1 receptor activation. However, nor UR-144 nor UR-144 N-pentanoic acid has no therapeutic application.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Phoenix Amphotropic (AMPHO) cell line were washed twice with Opti-MEM I Reduced Serum Medium to remove any remaining FBS, and 100 μL of Opti-MEM I was added. The Nano-Glo Live Cell reagent (Promega), a nonlytic detection reagent containing the cell permeable furimazine substrate, was prepared by diluting the Nano-Glo Live Cell substrate 20× using Nano-Glo LCS Dilution buffer, and 25 μL was added to each well. Subsequently, the plate was placed in a luminometer, the GloMAX96 (Promega). Luminescence was monitored during the equilibration period until the signal stabilized (30−45 min). For agonist experiments, we added 10 μL per well of test compounds (UR-144 N-pentanoic acid), present as 13.5× stocks in 50% methanol in Opti-MEM I. The luminescence was continuously detected for 120 min. Solvent controls were run in all experiments; the final concentration of methanol (3.7%) did not pose a problem given the short readout time of the assay.
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:56:21 GMT 2023
Edited
by admin
on Sat Dec 16 10:56:21 GMT 2023
Record UNII
1USZ174277
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
UR-144 N-PENTANOIC ACID
Common Name English
UR-144 N-PENTANOIC ACID METABOLITE
Common Name English
XLR-11 N-PENTANOIC ACID METABOLITE
Common Name English
UR-144 PENTANOIC ACID
Common Name English
1H-INDOLE-1-PENTANOIC ACID, 3-((2,2,3,3-TETRAMETHYLCYCLOPROPYL)CARBONYL)-
Systematic Name English
Code System Code Type Description
CAS
1451369-33-7
Created by admin on Sat Dec 16 10:56:21 GMT 2023 , Edited by admin on Sat Dec 16 10:56:21 GMT 2023
PRIMARY
PUBCHEM
86268508
Created by admin on Sat Dec 16 10:56:21 GMT 2023 , Edited by admin on Sat Dec 16 10:56:21 GMT 2023
PRIMARY
FDA UNII
1USZ174277
Created by admin on Sat Dec 16 10:56:21 GMT 2023 , Edited by admin on Sat Dec 16 10:56:21 GMT 2023
PRIMARY
EPA CompTox
DTXSID401043095
Created by admin on Sat Dec 16 10:56:21 GMT 2023 , Edited by admin on Sat Dec 16 10:56:21 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
10 ng/mL (urine, ER arrival), 58 ng/mL (serum, ER arrival), 32 ng/mL (serum, 10h after ER arrival)
IN-VIVO
URINE
PARENT -> METABOLITE
ND to 7.9 pg/mg authentic human hair samples (n=14)
IN-VITRO
Scientific Literature